Composition and method for treating a tauopathy
US9605054B2 · kind B2 · utility
6Cited by
1References
2Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 18, 2010 |
| Grant date | Mar 28, 2017 |
| Priority date | — |
| Expiry date | Feb 26, 2032 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/912
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is a composition and method for the prevention and treatment of a tauopathy. The composition of the invention includes N-terminal amino acid residues of the tau protein, which have been identified as being involved in toxic activation of a PP1/GSK3 signaling cascade and inhibition of fast axonal transport in human tauopathies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.